IMPROVE - Investigating Medication re-Purposing to Reduce risk of OVarian cancer and Extend survival

卵巢癌是导致妇女癌症死亡的第六大最常见原因，死于卵巢癌的妇女比例一直没有显著改善。这项大规模的研究将使用来自药品福利计划、澳大利亚癌症数据库和国家死亡指数的去识别数据，以调查通常用于其他疾病的药物是否有助于降低卵巢癌发展的风险或提高卵巢癌诊断后的生存率。

Ovarian cancer is the 6th most common cause of cancer death in women and the proportion of women who die from their disease has not improved substantially over time. This large-scale study will use de-identified data from the Pharmaceutical Benefits Scheme, the Australian Cancer Database and the National Death Index to investigate whether medications commonly used for other conditions can help decrease the risk of ovarian cancer developing or improve survival from ovarian cancer after diagnosis.